Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study

Jack Brownrigg(Pfizer (United Kingdom)), Robert J. Hinchliffe(North Bristol NHS Trust)
The Lancet Diabetes & Endocrinology
May 23, 2016
Cited by 243


Related Papers